The Performance and Benefits of Enteral Feeding Formulas Market: Analysis, Growth, and Trends 2022 - 2027

1
MarketsandMarkets Presents
Enteral Feeding Formulas Market worth 8.2
billion by 2027
https//www.marketsandmarkets.com/Market-Reports/e
nteral-feeding-formulas-market-74876393.html
2
The report "Enteral Feeding Formulas Market by
Product (Polymeric, Elemental, Disease-specific),
Stage (Adults, Pediatrics), Application
(Oncology, Gastroenterology, Neurology,
Hypermetabolism), End User (Hospitals, LTCF, Home
care) - Global Forecast to 2027", is projected to
reach USD 8.2 billion by 2027 from USD 5.2
billion in 2022, growing at a CAGR of 9.5 during
the forecast period. Factors such as benefits
of enteral nutrition over parenteral nutrition,
increase in cost for healthcare expensis, rise in
the number of preterm births, growing population
of gerartric patients, increased prevalence of
chronic diseases such as GI disorders,
neurological disorders, Diabetses, etc.,
increased awareness of enteral nutrition in
emerging countries are expected to improve market
growth. However, rising cases of feeding and
medication errors and underfeeding and the
complications associated with lack of skilled
proffesionals are restricting the growth of this
market to a certain extent. Also, insufficient or
lack of reimbursements in some developing and
underdeveloped countries and a dearth of trained
physicians across the globe pose significant
challenges for the growth of this
market. Download a PDF Brochure
https//www.marketsandmarkets.com/pdfdownload
3

• Objectives of the Study
• To validate the segmentation defined through the
  assessment of the product portfolios of the
  leading players in the market
• To understand key industry trends and issues
  defining the growth objectives of market players
• To gather both demand- and supply-side validation
  of the key factors affecting market growth,
  including market drivers, restraints,
  opportunities, and challenges
• To validate assumptions for the market sizing and
  forecasting model used for this market study
• To understand the market positions of the leading
  players in the enteral feeding formula market and
  their shares/rankings
• To understand the ongoing pricing trends in the
  market and future expectations
• Speak to Analyst https//www.marketsandmarkets.co
  m/speaktoanalyst

4
The study categorizes the enteral feeding formula
market based on product , stage, application, end
user and regional global level.

• Global enteral feeding formula market, by Product
• Standard Formula
• Disease specific
• Diabetic Formula
• Renal Formula
• Hepatic Formula
• Pulmonary Formula
• Other Disease Specific Formula
• Peptide based formula
• Other Formula
• Global enteral Feeding Formula Market, by
  Application
• Oncology
• Gastrointestinal Diseases
• Neurological Disorders
• Diabetes
• Other Applications

5

Abbott (US), Nestlé S.A. (Switzerland), Danone
S.A. (France), Fresenius Kabi (Germany), B. Braun
Melsungen AG (Germany), Otsuka Holding Co. Ltd.
(Japan), Nutritional Medicinals, LLC (US), Kate
Farms (US), Medtrition Inc. (US), Victus, Inc.
(US), Global Health Products, Inc. (US), Meiji
Holdings Co., Ltd. (Japan), Reckitt Benckiser
Group PLC. (UK), Hormel Foods Corporation (US),
DermaRite Industries, LLC. (US), Medline
Industries, LP. (US), Real Food Blends (US), and
Ajinomoto Cambrooke, Inc. (US) and Among others
6
Companies Insight
Nestlé is a multinational health, nutrition, and
wellness company. It manufactures and markets
milk-based products, pharmaceuticals, baby foods
and cereals, ophthalmic goods, and cooking aids.
The company operates in seven major business
segmentsPowdered and Liquid Beverages, Petcare,
Nutrition and Health Science, Prepared Dishes and
Cooking Aids, Milk Products and Ice cream,
Confectionary, and Water. The company provides a
range of enteral feeding formulas through its
Nestlé Health Science segment. In 2021, the
Nestlé Health Science segment contributed the
largest share of 5.5 to the companys revenue,
which was 3.9 in 2020. The continuous growth of
this segment is primarily due to its strong
product portfolio, brand recognition, and high
demand for nutritional formulas. In 2021 and
2022, the company acquired Orgain (US) and The
Bountiful Company (US), which enabled the company
to expand its presence in the market. The company
operates in over 186 countries across Zone EMENA
(Europe, Middle East, and North Africa), Zone AMS
(The Americas), and Zone AOA (Asia, Oceania, and
Africa). Fresenius Kabi has a strong global
footprint and focuses on providing high-quality,
innovative clinical nutrition solutions. The
company has a wide geographic presence in
established markets and a broad product portfolio
that includes nutritional supplements and tube
feed pediatric feed products. Along with this,
Fresenius Kabi supports external development
projects. The company also established the United
for Clinical Nutrition (UFCN) initiative to raise
awareness of disease-related malnutrition
worldwide. This has enabled the company to expand
its geographic presence.
7
Contact Us
ContactMr. Aashish MehraMarketsandMarkets
INC. 630 Dundee Road, Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 sales_at_marketsandmarkets
.com Press release https//www.marketsandmarkets
.com/PressReleases/enteral-feeding-formulas.asp R
esearch insights https//www.marketsandmarkets.co
m/ResearchInsight/enteral-feeding-formulas-market.
asp
8
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 5000 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.